DMII Drugs Made In America Acquisition II Corp. - Ordinary Shares
$10.12
Price · Aug 18, 2026
52W Range
$10–$10
76% of range
Analyst Rating
—
Price Target
—
P/E (TTM)
—
ROE
—
Net Profit Margin
—
DMII Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$10.12
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$10 – $10
DMII Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
DMII
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
DMII
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
DMII
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
DMII
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
DMII
Peer Median
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 67 filers · $416.1M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 6 (-13 vs prior Q) | 6 (+4 vs prior Q) | 14 (+4 vs prior Q) | 14 (-2 vs prior Q) | +1.8M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Karpus Management, Inc. | $28,047,260 | 2,787,998 | 6.74% | Shares |
| MMCAP International Inc. SPC | $27,162,000 | 2,700,000 | 6.53% | Shares |
| Magnetar Financial LLC | $27,162,000 | 2,700,000 | 6.53% | Shares |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | $22,569,035 | 2,241,215 | 5.42% | Shares |
| MILLENNIUM MANAGEMENT LLC | $20,055,193 | 1,993,558 | 4.82% | Shares |
| Hudson Bay Capital Management LP | $19,808,442 | 1,969,030 | 4.76% | Shares |
| WOLVERINE ASSET MANAGEMENT LLC | $18,663,533 | 1,855,222 | 4.48% | Shares |
| TENOR CAPITAL MANAGEMENT Co., L.P. | $15,090,000 | 1,500,000 | 3.63% | Shares |
| Polar Asset Management Partners Inc. | $15,090,000 | 1,500,000 | 3.63% | Shares |
| D. E. Shaw & Co., Inc. | $14,838,500 | 1,475,000 | 3.57% | Shares |
| AQR Arbitrage LLC | $11,380,536 | 1,131,266 | 2.73% | Shares |
| ARISTEIA CAPITAL, L.L.C. | $11,066,000 | 1,100,000 | 2.66% | Shares |
| Crossingbridge Advisors, LLC | $11,066,000 | 1,100,000 | 2.66% | Shares |
| First Trust Capital Management L.P. | $10,742,048 | 1,067,798 | 2.58% | Shares |
| Davidson Kempner Capital Management LP | $10,060,000 | 1,000,000 | 2.42% | Shares |
| OMERS ADMINISTRATION Corp | $10,060,000 | 1,000,000 | 2.42% | Shares |
| PICTON MAHONEY ASSET MANAGEMENT | $8,933,283 | 888,000 | 2.15% | Shares |
| TWO SIGMA INVESTMENTS, LP | $8,918,633 | 886,544 | 2.14% | Shares |
| Context Capital Management, LLC | $7,545,000 | 750,000 | 1.81% | Shares |
| Mercuria Capital Strategies, LLC | $7,545,000 | 750,000 | 1.81% | Shares |
| MOORE CAPITAL MANAGEMENT, LP | $7,545,000 | 750,000 | 1.81% | Shares |
| Ghisallo Capital Management LLC | $7,545,000 | 750,000 | 1.81% | Shares |
| Radcliffe Capital Management, L.P. | $5,791,753 | 575,721 | 1.39% | Shares |
| HighTower Advisors, LLC | $5,700,137 | 566,614 | 1.37% | Shares |
| Westchester Capital Management, LLC | $5,668,116 | 563,431 | 1.36% | Shares |
| HEIGHTS CAPITAL MANAGEMENT, INC | $5,225,164 | 519,400 | 1.26% | Shares |
| TIG Advisors, LLC | $5,030,000 | 500,000 | 1.21% | Shares |
| HBK INVESTMENTS L P | $5,030,000 | 500,000 | 1.21% | Shares |
| BlueCrest Capital Management Ltd | $5,030,000 | 500,000 | 1.21% | Shares |
| WHITEBOX ADVISORS LLC | $4,527,000 | 450,000 | 1.09% | Shares |
| Wealthspring Capital LLC | $4,028,426 | 400,440 | 0.97% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $3,973,197 | 394,950 | 0.95% | Shares |
| Logan Stone Capital, LLC | $3,839,761 | 381,686 | 0.92% | Shares |
| CANTOR FITZGERALD, L. P. | $3,652,786 | 363,100 | 0.88% | Shares |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | $3,521,000 | 350,000 | 0.85% | Shares |
| Lineage Point Capital LP | $3,383,782 | 336,360 | 0.81% | Shares |
| Kryger Capital LLC | $3,063,682 | 304,541 | 0.74% | Shares |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | $3,039,000 | 300,000 | 0.73% | Shares |
| Periscope Capital Inc. | $2,263,500 | 225,000 | 0.54% | Shares |
| Clear Street Group Inc. | $2,262,283 | 224,879 | 0.54% | Shares |
| Verition Fund Management LLC | $2,040,570 | 202,840 | 0.49% | Shares |
| Shaolin Capital Management LLC | $1,815,669 | 180,484 | 0.44% | Shares |
| GABELLI & Co INVESTMENT ADVISERS, INC. | $1,805,770 | 179,500 | 0.43% | Shares |
| Limestone Investment Advisors LP | $1,519,060 | 151,000 | 0.37% | Shares |
| HGC Investment Management Inc. | $1,509,000 | 150,000 | 0.36% | Shares |
| GABELLI FUNDS LLC | $1,337,980 | 133,000 | 0.32% | Shares |
| JPMORGAN CHASE & CO | $1,305,374 | 129,630 | 0.31% | Shares |
| Schonfeld Strategic Advisors LLC | $1,125,532 | 111,882 | 0.27% | Shares |
| TORONTO DOMINION BANK | $1,045,465 | 103,923 | 0.25% | Shares |
| Centiva Capital, LP | $1,006,000 | 100,000 | 0.24% | Shares |
| DLD Asset Management, LP | $1,006,000 | 100,000 | 0.24% | Shares |
| PEAK6 LLC | $1,006,000 | 100,000 | 0.24% | Shares |
| PenderFund Capital Management Ltd. | $799,770 | 79,500 | 0.19% | Shares |
| Arax Advisory Partners | $663,859 | 65,990 | 0.16% | Shares |
| UBS Group AG | $439,300 | 43,668 | 0.11% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $398,868 | 39,649 | 0.10% | Shares |
| ABC ARBITRAGE SA | $352,100 | 35,000 | 0.08% | Shares |
| Dakota Wealth Management | $308,339 | 30,650 | 0.07% | Shares |
| ROBINSON CAPITAL MANAGEMENT, LLC | $251,500 | 25,000 | 0.06% | Shares |
| ROYAL BANK OF CANADA | $192,000 | 19,081 | 0.05% | Shares |
| SONA ASSET MANAGEMENT (US) LLC | $150,900 | 15,000 | 0.04% | Shares |
| Tuttle Capital Management, LLC | $108,336 | 10,769 | 0.03% | Shares |
| GLAZER CAPITAL, LLC | $23,573 | 2,343,278 | 0.01% | Shares |
| Mint Tower Capital Management B.V. | $2,515 | 250,000 | 0.00% | Shares |
| Kepos Capital LP | $2,113 | 210,000 | 0.00% | Shares |
| MORGAN STANLEY | $634 | 63 | 0.00% | Shares |
| Virtu Financial LLC | $299 | 29,744 | 0.00% | Shares |
Company insiders 6 insiders · 2 officers · 4 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Lynn Stockwell | CEO and Exe. Chair of Board | Sept. 26, 2025 P | 6,708,333 | 0 | 0 | $0 |
| Glenn C. Worman | CFO | Sept. 26, 2025 J | 100,000 | 0 | 0 | $0 |
| Catherine Do | Director | Sept. 26, 2025 J | 100,000 | 0 | 0 | $0 |
| Myron W. Shulgan | Director | Sept. 26, 2025 J | 100,000 | 0 | 0 | $0 |
| Sridhar G. Prasad | Director | Sept. 26, 2025 J | 100,000 | 0 | 0 | $0 |
| Drugs Made In America Acquisition II LLC | 10% owner | Sept. 26, 2025 P | 6,708,333 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Drugs Made In America Acquisition II LLC, Lynn Stockwell | Oct. 2, 2025 | 10.20% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.